Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Tricuspid regurgitation is a common finding in patients with left-sided valvular or myocardial
disease, often being a marker for late-stage chronic heart failure with a grim prognosis …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …

Background Tricuspid regurgitation is a prevalent disease associated with high morbidity
and mortality, with few treatment options. The aim of the TRILUMINATE trial is to evaluate …

In minimally invasive endovascular procedures, surgeons rely on catheters with low
dexterity and high aspect ratios to reach an anatomical target. However, the environment …

Background Tricuspid regurgitation (TR) is a prevalent disease with limited treatment
options. Objectives This is the first 30-day report of the US single-arm, multicenter …

Objectives The purpose of this observational first-in-human experience was to investigate
the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact …

Objectives The purpose of this study was to introduce a novel clinically relevant
nomenclature system for the TV and determine the relative incidence of each morphological …

Background: Patients with isolated tricuspid regurgitation (TR) in the absence of left-sided
valvular dysfunction are often managed nonoperatively. Objectives: The purpose of this …